The most complete and dynamic source of pharmaceutical manufacturing and supply chain intelligence
A subscription-based database that provides clients with an in-depth view into manufacturing capabilities of generics firms, biosimilars developers and contract manufacturers
Key Features:
Exhaustive list of manufacturers with over 2,000 firms profiled and additional firms added weekly
Global coverage including emerging markets (China, India, Latin America, Middle East, North Africa and Asia Pacific markets)
Mobile / Tablet friendly access with a simple log in
SAI Primary CI Research support for in-depth analysis
Critical Decision Support:
Identify potential generic and biosimilar threats based on production capabilities
Evaluate likely CMO/CDMO partners for manufacturing needs
Track potential product supply shortages by identifying facilities with operational issues, regulatory inspection warnings, etc.
Identify API sources for supply redundancies and improving manufacturing efficiencies
Aggregate data categorized into two distinct modules:
Company profiles and analyses on product capabilities, locations, etc.
Global facility maps
Granular facility / unit level capabilities on product
types, etc.
Regulatory inspection and capacity information
Includes API suppliers and CMO / CDMO
Granular insights into biologics (mAbs, proteins, etc.) manufacturing capabilities
Global facilities mapping including manufacturing process type